Finding new ways to treat osteoarthritis pain
Validation of Novel Target for OA Treatment
This study is looking at how a substance called VEGF affects joint pain in people with osteoarthritis, with the goal of finding new ways to help manage pain and slow down the disease for those living with this condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Chicago NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project ID | NIH-10055369 on NIH RePORTER |
What this research studies
This research focuses on osteoarthritis (OA), a common and debilitating condition affecting millions of Americans. It aims to identify and validate new therapeutic targets that can help manage pain and slow disease progression. The approach involves studying the role of vascular endothelial growth factor (VEGF) in OA, as increased levels of VEGF are linked to joint pain and disease severity. By exploring inhibitors of the VEGF pathway, the research seeks to develop more effective treatments for OA patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from osteoarthritis, particularly those experiencing significant joint pain.
Not a fit: Patients with osteoarthritis who are not experiencing pain or those with other unrelated conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new, more effective treatments for managing osteoarthritis pain and potentially slowing the progression of the disease.
How similar studies have performed: Previous research has shown promise in targeting the VEGF pathway for various conditions, suggesting potential for success in treating osteoarthritis.
Where this research is happening
Chicago, UNITED STATES
- University of Illinois at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Royston, Thomas J — University of Illinois at Chicago
- Study coordinator: Royston, Thomas J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.